Enara Bio
Ervaxx is illuminating the immune interface to develop new cancer therapies.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Enara Bio Information
Geographic Data
Address: The Magdalen Centre Oxford Science Park 1 Robert Robinson Avenue
City: Oxford
State: england
Zip: OX4 4GA
Country: GB
Financial Info
Stage:
series a
Raised Last:
$18M
Raised Total:$18M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Enara Bio is a science-led company targeting the T-cell/cancer cell interface (the “immune synapse”) to develop new targeted cancer immunotherapies designed to treat a broad patient population. Enara Bio focuses on discovering and developing therapeutic cancer vaccines utilizing novel antigens derived from endogenous retroviral (ERV)-related DNA sequences.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2018 | Seed Round | 1 | - |
RA Capital Management RA Capital Management |
11/2019 | Series A | 1 | $17.5M |
SV Health Investors SV Health Investors |
12/2018 | Seed Round | 1 | - |
RA Capital Management RA Capital Management |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
